Logo image
Back
Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: A cautionary tale
Journal article   Peer reviewed

Recognition of giant cell arteritis in patients with polymyalgia rheumatica who have a stroke: A cautionary tale

D.H. Gutteridge and F.L. Mastaglia
Internal Medicine Journal, Vol.47(10), pp.1199-1201
2017
DOI: https://doi.org/10.1111/imj.13567
url
Link to Published Version *Subscription may be requiredView

Abstract

An 82-year-old woman with polymyalgia rheumatica (PMR) on prednisone 7 mg daily was admitted to an acute stroke unit with a right homonymous hemianopia, a left posterior cerebral artery occlusion and occipital lobe infarct. She had raised inflammatory markers, did not have a temporal artery biopsy, and was discharged on the same dose of prednisone. After 21 months, off prednisone, her ophthalmologist, concerned about giant cell arteritis (GCA), restarted prednisone 40 mg daily, with rapid, profound visual improvement. After 3 days her general practitioner, noting normal baseline inflammatory markers, stopped treatment-with rapid visual reversion. It is critical to recognise GCA in patients with PMR admitted to a stroke unit and not to withdraw prematurely corticosteroids once commenced.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

51 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.208 Vasculitis & Autoimmune Disorders
1.208.1579 Large Vessel Vasculitis
Web Of Science research areas
Rheumatology
ESI research areas
Clinical Medicine
Logo image